EndoCard
Sources: the KBO register on 19-11-2026; the National Bank, annual accounts to 31-03-2026 filed on 23-10-2026; the Belgian Official Gazette, latest deed of 28-11-2024.
Grounds
the facts the verdict rests on, each with its source- EndoCard made a profit in every financial year since 2019. The profit of 2026, €650,049, is the highest so far.Annual accounts 2019 to 2026 page 2
- Equity stands at €669,936, or 28.1% of the balance sheet total of €2.4m.Annual accounts to 31-03-2026 page 2
- EndoCard paid out €614,000 in dividends, 94% of the profit of 2026.Annual accounts to 31-03-2026 page 2
- Of the €1.7m of debt, €1.0m runs for more than a year.Annual accounts to 31-03-2026, notes page 2
- The last five annual accounts came in on time. The accounts to 31-03-2026 were filed 8 days before the end of the term.National Bank, filing of 23-10-2026 page 4
Representation
The signing rule is in the deed of 31-12-2021.
Articles of association, Belgian Official Gazette of 31-12-2021, deed 21380269
Ownership
The accounts in the micro format list no shareholders. is mandate holder. There is one other shareholder.
Deed of 31-12-2021
Financial situation
Annual accounts 2022 to 2026, as filed with the National Bank
Gross margin and net resultin €m
Equity and debtsin €m
Cashin €m
| Financial year | 2022 | 2023 | 2024 | 2025 | 2026 | Trend |
|---|---|---|---|---|---|---|
| Results | ||||||
| Gross margin | €558,437 | €583,744 | €949,380 | €936,150 | €998,754 | |
| Operating result | €554,884 | €349,302 | €879,472 | €856,040 | €908,867 | |
| Net result | €424,035 | €246,985 | €645,661 | €615,287 | €650,049 | |
| Balance sheet at the closing date | ||||||
| Equity | €18,600 | €265,585 | €666,246 | €633,887 | €669,936 | |
| Debts | €468,537 | €1.7m | €1.7m | €1.7m | €1.7m | |
| Debts due after more than one year | - | €1.3m | €1.2m | €1.1m | €1.0m | |
| Debts due within one year | €468,537 | €358,884 | €421,091 | €532,652 | €644,059 | |
| Cash | €220,921 | €190,491 | €363,040 | €536,829 | €328,463 | |
| Balance sheet total | €487,137 | €2.0m | €2.3m | €2.3m | €2.4m | |
| Ratios | ||||||
| Solvency | 3.8% | 13.4% | 28.7% | 27.3% | 28.1% | |
| Liquidity | 0.90 | 1.11 | 1.87 | 1.48 | 1.44 | |
Source: Annual accounts to 31-03-2026, micro format, filed on 23-10-2026 (2026-00568458); Annual accounts to 31-03-2025, micro format, filed on 24-10-2025 (2025-00550396); Annual accounts 2022 to 2024, filed from 27-10-2022 to 25-10-2024 (2022-20476723, 2023-00503663, 2024-00516658).
The annual accounts to 31-03-2026 state no amount of overdue tax or social security (RSZ) debts.
EndoCard states no turnover; the micro format does not require it. The gross margin, what is left after purchases, rose from €936,150 to €998,754.
Board, signature and ownership
Position on 19-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts
Who represents the company
The signing rule is in the deed of 31-12-2021.
Articles of association, Belgian Official Gazette of 31-12-2021, deed 21380269
Board
two directors in officeOwnership and group
Shareholders
The accounts in the micro format list no shareholders. is mandate holder. is mandate holder.
Deed of 31-12-2021
Board changes
(director) and (director) reappointed. General meeting of 04-06-2024.
Gazette, deed 24168556Events and comparison
Every event since the founding, newest first
Annual accounts 2026 filed, 8 days before the deadline.
NBB filingHighest result from 2019 to 2026. The operating result of €908,867 and the net result of €650,049 are both a record.
FinancialAnnual accounts 2025 filed, 7 days before the deadline.
NBB filingAnnual accounts 2024 filed, 6 days before the deadline.
NBB filingAnnual accounts 2023 filed, 1 day before the deadline.
NBB filingWeakest financial year. The net result drops to €246,985, the lowest from 2019 to 2026. It recovers the following year.
FinancialAnnual accounts 2022 filed, 4 days before the deadline.
NBB filingCompany renamed from Dr. Nick Hiltrop-Dr. to EndoCard. “De uitoefening van de geneeskunde door de artsen-aandeelhouders, meer bepaald van de geneeskunde met…” (deed in Dutch). Partner: (mandate holder). Partner: (mandate holder). General meeting of 21-12-2021.
Gazette, deed 21380269Annual accounts 2021 filed, 31 days before the deadline.
NBB filingAnnual accounts 2020 filed, 44 days before the deadline.
NBB filingEquity above €500,000. With a profit in every financial year since 2019, equity grows to €549,144.
FinancialAnnual accounts 2019 filed, 3 days before the deadline.
NBB filingIncorporation. Founding capital of €18,600, 100 shares. Founded by ; . (manager) and (manager) appointed. Published on 11-06-2018.
Gazette, deed 18316826Comparable companies, two years later
In July 2024, 2,684 companies had the same profile as EndoCard has now: small, 5 to 10 years old, solvency 10 to 30% and a profit of 5% of the balance sheet or more. Two years later 97.2% were still trading, 1.4% had stopped another way and 1.3% had gone bankrupt.
Other findings
Peppol
Reachable for e-invoices since 24-11-2024, under 0208:0697720802.
Sanctions lists
Sources and method
Where each fact in this report comes from
| Source | What | Date | Reference |
|---|---|---|---|
| KBO register | Registration, legal situation, activity, establishment units | 19-11-2026 | KBO 0697.720.802 |
| National Bank of Belgium | Annual accounts to 31-03-2026, micro format | 23-10-2026 | 2026-00568458 |
| National Bank of Belgium | Annual accounts to 31-03-2025, micro format | 24-10-2025 | 2025-00550396 |
| National Bank of Belgium | Annual accounts 2022 to 2024 | 27-10-2022 to 25-10-2024 | 2022-20476723, 2023-00503663, 2024-00516658 |
| Belgian Official Gazette | Board | 28-11-2024 | deed 24168556 |
| Belgian Official Gazette | Articles of association with the signing rule | 31-12-2021 | deed 21380269 |
| Peppol Directory | Registration for e-invoices | 24-11-2024 | 0208:0697720802 |
| Sanctions lists EU, UN, US (OFAC) and UK | Comparison of the name | 19-11-2026 | |
| Checked | Checked score, bankruptcy probability, credit, comparable companies | 18-11-2026 | bankruptcy model of 2 October 2026 |
Method
Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.
Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 18-11-2026.
Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.
Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.
The scores and ratios are Checked's own calculations, not a credit decision.